CAS 116289-53-3

Formule : C25H19N3O2S

InChI : InChI=1S/C25H19N3O2S/c29-23(17-6-2-1-3-7-17)18-8-4-10-20(14-18)27-24(30)21-11-13-28-22(21)16-31-25(28)19-9-5-12-26-15-19/h1-15,25H,16H2,(H,27,30)/t25-/m1/s1

Code InChI : PQQFNXGONTVQLM-RUZDIDTESA-N

SMILES : C1C2=C(C=CN2[C@H](S1)C3=CN=CC=C3)C(=O)NC4=CC=CC(=C4)C(=O)C5=CC=CC=C5

Tulopafant

CAS : 116289-53-3

Tulopafant

Formule : C₂₅H₁₉N₃O₂S

Degré de pureté : ≥98%

Masse moléculaire : 425.5

Ref: 54-BUP21633

Tulopafant

CAS : 116289-53-3

Ref: IN-DA008YY6

Tulopafant

CAS : 116289-53-3

Tulopafant is a novel linker drug that has shown efficacy in treating ischemia/reperfusion injury. It acts by binding to and activating neutrophils, which are important for the body's immune response to infection. Tulopafant promotes the release of reactive oxygen species from neutrophils, and it also neutralizes reactive nitrogen species. This drug has been shown to be effective in reducing ventricular fibrillation in vitro studies and may be useful as a treatment for myocardial infarcts.

Formule : C₂₅H₁₉N₃O₂S

Degré de pureté : Min. 95%

Masse moléculaire : 425.5 g/mol

Ref: 3D-REA28953

Tulopafant

CAS : 116289-53-3

Tulopafant (RP 59227) is a potent platelet-activating factor (PAF) antagonist that increases capillary patency and prolongs allograft heart survival.

Formule : C₂₅H₁₉N₃O₂S

Degré de pureté : 99.38%

Couleur et forme : Yellow Solid

Masse moléculaire : 425.5

Ref: TM-T17178